Selective. Targeted. Innate.

NanoGhost is a pre‐clinical‐stage synthetic biology company engineering next‐generation cancer detection and treatment agents. The company manufactures off‐the‐shelf mesenchymal stem‐cell derived nano‐ vesicles loaded with a variety of therapeutics, resulting in potentially safe and targeted delivery of anti‐cancer agents directly to the tumor. NanoGhost’s proprietary engineering and manufacturing know‐how results in consistent, precise and efficient targeted delivery of therapeutics to sites of cancer and inflammation, with the potential to revolutionize current treatment modalities and survival.

Investing partner / fund: